TFF Pharmaceuticals an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions. TFF Pharmaceuticals has generated numerous formulations for faster and more complete dry powder delivery to the lungs.

Biotechnology

Pharmaceutical

TFF Pharmaceuticals, Inc.

Harlan Weisman

Chris Cano

G.J. Davenport

Zamaneh Mikhak

Kirk Coleman

Ted M. Ross

David Denning

Aaron Fletcher

Mike Saag

Robert O. Williams III

Anthony Hickey

Jay Peters

Drew Weissman

David N. Cornfield

Brandi Roberts

Robert S. Mills

Stephen Rocamboli

The Scientific Advisory Team at TFF Pharmaceuticals plays a critical role in guiding the company's development of innovative drug products for lung diseases. Comprising experts in various fields, the team provides strategic insights, evaluates research directions, and ensures that scientific advancements are both cutting-edge and aligned with the company's goals for faster and more effective dry powder lung delivery systems.

Scientific Advisory Team

The Leadership Team at TFF Pharmaceuticals, Inc. is responsible for steering the strategic direction and overall administration of the company. Comprising high-level executives such as the CEO, CFO, Chief Medical Officer, and various Vice Presidents, this team oversees government relations, strategic initiatives, business development, preclinical research, product development, and manufacturing to ensure the successful development and commercialization of innovative drug products for lung diseases.

Leadership Team

The Board Members at TFF Pharmaceuticals, Inc. provide strategic oversight, governance, and direction to ensure the company's goals in developing and commercializing innovative drug products for lung diseases are met. They work closely with the executive team to guide major decisions, assess risks, and ensure regulatory compliance and financial health.

Board Members

The Product Development Team at TFF Pharmaceuticals, Inc. focuses on formulating and optimizing innovative dry powder drug products for the treatment of lung diseases. They are responsible for overseeing the development process from inception through manufacturing, ensuring faster and more effective delivery of medications to the lungs.

Product Development Team

The Strategic and Regulatory Affairs team at TFF Pharmaceuticals, Inc. is responsible for navigating and ensuring compliance with governmental and regulatory frameworks, crafting strategic initiatives to advance the company's drug products, and identifying business opportunities for growth and commercialization. The team collaborates to keep abreast of industry regulations, manage regulatory submissions, and align strategic goals with business development efforts to optimize the delivery and market introduction of innovative lung disease treatments.

Strategic And Regulatory Affairs

TFF Pharmaceuticals, Inc.

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Board Members

Product Development Team

Strategic And Regulatory Affairs

Offices

TFF Pharmaceuticals, Inc.

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Board Members

Product Development Team

Strategic And Regulatory Affairs

Offices

Related companies